<p>Odds ratios for <i>DRB1*1501</i>: For MS vs. Controls = 2.33 (95% CI: 1.54–3.53, <i>p</i><0.001). For Non-progressive vs. Progressive MS = 1.03 (0.62–1.72, <i>p</i> = 1.0).</p><p>Odds ratios for CCSVI status: For MS vs. Controls = 4.52 (95% CI: 2.88–7.10, <i>p</i><0.001). For Non-progressive vs. Progressive MS = 2.36 (1.37–4.07, <i>p</i> = 0.002).</p
<p>a: differences in the number of individuals who carried the <i>HLA-DRB1</i> allele, comparing PBC...
<p>0 risk alleles (no DR3 no DR4); 1 risk allele (DR3 or DR4); 2 risk alleles (DR3/3, DR4/4 or DR3/4...
Patients with a double dose of HLA-DQB1*02 had classical CD more frequently compared to those having...
<p>The joint distribution of the <i>HLA DRB1*1501</i> status and CCSVI status.</p
<p>p<sup>uncorr</sup> was corrected by multiplying the value by 17 to calculate p<sup>corr</sup>.</p...
<p>p<sup>uncorr</sup> was corrected by multiplying the value by 18 to calculate p<sup>corr</sup>.</p...
<p>*<sup>a</sup>Compared with HCs, p<sup>corr</sup> = 0.0196, OR = 2.217, 95% CI = 1.389–3.539.</p...
<p><b>A</b> Odds ratio (OR) for <i>DRB1</i> alleles and genotypes from logistic regression analyses ...
<p>p<sup>uncorr</sup> was corrected by multiplying the value by 10 to calculate p<sup>corr</sup>.</p...
<p>Odds ratio (and its 95% confidence intervals) for the carriers of <i>HLA-B</i> and-<i>DRB1</i> al...
<p>The HLA-A*02 negative individuals constitute the reference group. Bars indicate the 99% confidenc...
<p>DRB1-DQB1 haplotypes in MS patients (col.1), the number observed (col. 2) and expected from contr...
*a<p>p<sup>corr</sup> = 0.0324, as compared with HCs.</p>*b<p>p<sup>corr</sup> = 0.0033, as compared...
<p>Chromosomes carrying both <i>DRB1*15</i> and the protective class I haplotype do not differ in ri...
<p>wGRS (weighted Genetic Risk Score) has been calculated using the ORs for the 52 non-HLA MS suscep...
<p>a: differences in the number of individuals who carried the <i>HLA-DRB1</i> allele, comparing PBC...
<p>0 risk alleles (no DR3 no DR4); 1 risk allele (DR3 or DR4); 2 risk alleles (DR3/3, DR4/4 or DR3/4...
Patients with a double dose of HLA-DQB1*02 had classical CD more frequently compared to those having...
<p>The joint distribution of the <i>HLA DRB1*1501</i> status and CCSVI status.</p
<p>p<sup>uncorr</sup> was corrected by multiplying the value by 17 to calculate p<sup>corr</sup>.</p...
<p>p<sup>uncorr</sup> was corrected by multiplying the value by 18 to calculate p<sup>corr</sup>.</p...
<p>*<sup>a</sup>Compared with HCs, p<sup>corr</sup> = 0.0196, OR = 2.217, 95% CI = 1.389–3.539.</p...
<p><b>A</b> Odds ratio (OR) for <i>DRB1</i> alleles and genotypes from logistic regression analyses ...
<p>p<sup>uncorr</sup> was corrected by multiplying the value by 10 to calculate p<sup>corr</sup>.</p...
<p>Odds ratio (and its 95% confidence intervals) for the carriers of <i>HLA-B</i> and-<i>DRB1</i> al...
<p>The HLA-A*02 negative individuals constitute the reference group. Bars indicate the 99% confidenc...
<p>DRB1-DQB1 haplotypes in MS patients (col.1), the number observed (col. 2) and expected from contr...
*a<p>p<sup>corr</sup> = 0.0324, as compared with HCs.</p>*b<p>p<sup>corr</sup> = 0.0033, as compared...
<p>Chromosomes carrying both <i>DRB1*15</i> and the protective class I haplotype do not differ in ri...
<p>wGRS (weighted Genetic Risk Score) has been calculated using the ORs for the 52 non-HLA MS suscep...
<p>a: differences in the number of individuals who carried the <i>HLA-DRB1</i> allele, comparing PBC...
<p>0 risk alleles (no DR3 no DR4); 1 risk allele (DR3 or DR4); 2 risk alleles (DR3/3, DR4/4 or DR3/4...
Patients with a double dose of HLA-DQB1*02 had classical CD more frequently compared to those having...